| 1 |
de Klein A, van Kessel AG, Grosveld G, et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia[J]. Nature, 1982, 300(5894): 765-767.
|
| 2 |
Novo G, Di Lisi D, Bronte E, et al. Cardiovascular toxicity in cancer patients treated with tyrosine kinase inhibitors: a real-world single-center experience[J]. Oncology, 2020, 98(7): 445-451.
|
| 3 |
Talati C, Pinilla-Ibarz J. Resistance in chronic myeloid leukemia: definitions and novel therapeutic agents[J]. Curr Opin Hematol, 2018, 25(2): 154-161.
|
| 4 |
Singh AP, Prachi U, Tousif S，et al. Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: emphasis on ponatinib[J]. Int J Cardiol, 2020, 316: 214-221.
|
| 5 |
Hochhaus A, Baccarani M, Silver RT, et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia[J]. Leukemia, 2020, 34(4): 966-984.
|
| 6 |
Casavecchia G, Galderisi M, Novo G, et al. Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib[J]. Heart Fail Rev, 2020, 25(3): 447-456.
|
| 7 |
Cortes JE, Kantarjian H, Shah NP, et al. Ponatinib in refractory philadelphia chromosome-positive leukemias[J]. N Engl J Med, 2012, 367(22): 2075-2088.
|
| 8 |
Cortes JE, Kim DW, Pinilla-Ibarz J, et al. Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial[J]. Blood, 2018, 132(4): 393-404.
|
| 9 |
Singh AP, Glennon MS, Umbarkar P, et al. Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies[J]. Cardiovasc Res, 2019, 115(5): 966-977.
|
| 10 |
Tousif S, Singh AP, Umbarkar P, et al. Ponatinib drives cardiotoxicity by S100A8/A9-NLRP3-IL-1β mediated inflammation[J]. Circ Res, 2023, 132(3): 267-289.
|
| 11 |
Jiang Q, Li Z, Qin Y, et al. Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial[J]. J Hematol Oncol, 2022, 15(1): 113.
|